Antibodies Companies (15)

Antibodies News

Antibodies Products (27)

  • Product Bispecific Antibody Characterisation

    Characterisation of bispecific antibodies supporting regulatory considerations for therapeutic development. Our scientists offer BsAb characterisation, with a focus on monitoring relevant CQAs. We can help you to demonstrate consistency or comparability of manufactured batches or as release tests for clinica...
  • Product New plant, Plant 4

    To fulfill the increasing demand of life-saving solutions for patients' lives all over the world, we decided to drive forward with building our new facility, Plant 4. Our accumulated expertise is implemented with the latest technologies and innovation, so that Plant 4 will be able to serve as part of your glo...

    Csv Life Science offers Conceptual, Basic and Detail Engineering services.
  • Product Filgrastim (g-csf)

    Axxo gmbh offers biopharmaceutical products which includes filgrastim (g-csf). It belongs to recombinant human proteins products category. It is for post-cancer treatment. Contact us for more information.
  • Product Contract Manufacturing (CDMO/CRO/CMO)

    We are world's leading contract manufacturer.  
  • Product Antibody Drug Conjugates

    Syngene’s Antibody Drug Conjugate (ADC) unit brings together an array of multidisciplinary capabilities in antibody generation, linker and payload chemistry, conjugation chemistry, in vitro and in vivo oncology in an integrated platform.
  • Product Oxacillin sodium compacted

    Centrient Pharmaceuticals provides wide range of semi-synthetic penicillins which includes oxacillin sodium compacted. Characteristics: granules obtained by means of dry compaction of the crystalline powder without adding any excipients. Application: the product is suitable for the manufacture of capsules and...
  • Product S-Cellerate™ to IND

    Speed to market is becoming increasingly crucial for commercial success. Enhanced timelines, which quickly advance the platform product to proof-of-concept (PoC) and first-in-human (FiH) studies, are already the new norm. Samsung Biologics’ S-Cellerate™ represents the faster path to IND, achieved through care...
  • Product S-Cellerate™ to BLA

    As biologics in development get closer to commercialization, drug developers are expected to implement rigorous process control measures to avoid potential manufacturing inconsistencies. A thorough understanding of process parameters and their potential impact on the product quality attributes and safety prof...
  • Product Comparability Studies for Biopharmaceuticals

    We design bespoke analytical programmes that ensure that the relevant quality attributes for your drug substance or product are evaluated to support your manufacturing process changes. We select analytics referenced by the ICH Q6B to examine the product's structural features (primary, secondary and ...
  • Product Biologic Quality Control and Release Testing

    We deliver responsive QC analysis for complex biologic products from our cGMP laboratories. Our scientists develop and validate methods or perform technology transfer of a sponsor's method for a wide range of analytical methods required for batch release testing. We also routinely carry out testing to Pharmac...
  • Product cGMP Cell-based Bioassays

    Cell-based bioassays that comply with cGMP: Using a variety of techniques, including cell-based assays, ligand and receptor binding assays, and flexible multiple assay approaches – our potency testing experts offer tailored bioassay method development, method transfer and method validation to ICH Q2 (R1) s...
  • Product Protein Therapeutic Glycosylation Studies

    In line with ICH Q6B, we deliver glycosylation analysis for proteins, antibodies, bispecifics including assessment of the glycosylation site, carbohydrate content and glycan structure. With a range of MS approaches, our protein characterisation scientists provide detailed glycosylation studies designed to sup...
  • Product Antibody / Monoclonal antibody therapeutics services

    Monoclonal antibody therapeutics: We continually invest in advanced analytical instrumentation that allows us to deliver mAb analytical data with the highest degree of sensitivity, accuracy and resolution. Our experience spans recombinant monoclonal antibodies and related products such as biosimilars, fus...
  • Product Protein Aggregation Analysis and Characterization

    Analysis and characterization of protein aggregates: The services provided by our experts include a range of protein aggregation analysis techniques that are used to detect and quantify aggregates in solution in support of formulation development, quality control, stability studies, comparability, releas...
  • Product Post-translational modifications

    Intertek offers wide range of pharmaceutical services which includes post-translational modifications. It belongs to biopharmaceutical protein analysis services category. It includes deamidation, glycosylation, glycylation, phosphorylation, acetylation , alkylation, sulfation, etc.
  • Product 6-Maleimidocaproic Acid(CAS#55750-53-3)

    6-Maleimidocaproic Acid(CAS#55750-53-3)
  • Product 汉利康® (pronounced as Han-Li-Kang) Rituximab Injection

    汉利康® (pronounced as Han-Li-Kang) Rituximab Injection.  It is the first-ever China-manufactured biosimilar approved by the NMPA for the treatment of non-Hodgkin lymphoma (NHL).  Meanwhile, we are also conducting a Phase 3 clinical trial for rheumatoid arthritis (RA) for HLX01 in China.  汉利康...
  • Product TALMUSIN-0.4

    Tamsulosin Hydrochloride Tablets 
  • Product Sterile Products Contract Manufacturing

    Our main CDMO activity is the large scale manufacturing of injectable products in our internationally reputed site in Pau (France). The site is organized around 9 independent workshops, specialized in the aseptic filling under isolators of potent molecules such as anticancer cytotoxics, monoclonal antibo...

Upcoming Events

  • CPHI Korea 2022

    COEX, Seoul, Korea
    28 - 30 September 2022
  • CPHI Frankfurt 2022

    Messe Frankfurt, Frankfurt, Germany
    1-3 November 2022
  • CPHI & PMEC India 2022

    India Expo Centre, Greater Noida, Delhi NCR
    29 November - 1 December

Pharmaceutical Industry Webinars